Lung cancer study maps genetic resistance to guide next steps
NCT ID NCT05219162
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 34 times
Summary
This study looked at gene changes in 182 people with advanced lung cancer whose disease got worse after first treatment with osimertinib. Researchers collected tissue and blood samples to find out why the drug stopped working. The goal is to help doctors choose better treatments after osimertinib fails.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED NSCLC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Beijing, 100210, China
-
Research Site
Changsha, 410013, China
-
Research Site
Chengdu, 610014, China
-
Research Site
Dalian, 116023, China
-
Research Site
Foshan, 528000, China
-
Research Site
Fuzhou, 350014, China
-
Research Site
Harbin, 150081, China
-
Research Site
Hefei, 230001, China
-
Research Site
Hefei, 230601, China
-
Research Site
Linhai, 317000, China
-
Research Site
Luoyang, 471003, China
-
Research Site
Rizhao, 276826, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Taizhou, 225300, China
-
Research Site
Tianjin, 300060, China
-
Research Site
Zhengzhou, 450000, China
Conditions
Explore the condition pages connected to this study.